| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 04/10/2002 | CN1344247A Multicyclic compounds which inhibit beukocyte adhesion mediated by VLA-4 |
| 04/09/2002 | US6369226 Substituted benzamide inhibitors of rhinovirus 3C protease |
| 04/09/2002 | US6369067 Monocyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them |
| 04/04/2002 | WO2002026697A2 Aromatic derivatives with hiv integrase inhibitory properties |
| 04/04/2002 | WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 04/04/2002 | WO2002004407A3 7-substituted tetracycline compounds |
| 04/04/2002 | US20020040162 Contrast media for angiography |
| 04/04/2002 | US20020040003 Tyrosine phosphatase inhibitors useful in the treatment or prevention of Type II Diabetes Mellitus |
| 04/04/2002 | US20020039769 Chemical intermediates; hydrolysis using hydrolases |
| 04/04/2002 | DE10044792A1 Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung Substituted Phenylcyclohexancarbonsäureamide and their use |
| 04/03/2002 | EP1193271A2 Compositions and methods for protein structural determinations |
| 04/03/2002 | EP1192135A2 Serine protease inhibitors |
| 04/03/2002 | EP1192132A2 Serine protease inhibitors |
| 04/03/2002 | EP1192127A1 Substituted benzamide inhibitors of rhinovirus 3c protease |
| 04/03/2002 | EP0874645B1 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics |
| 04/03/2002 | EP0716600B1 Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| 04/03/2002 | CN1343219A Substituted phenethylamine derivatives |
| 04/03/2002 | CN1082044C Improved technology for chemical synthesizing L-asparagine |
| 04/03/2002 | CN1082043C Novel cationic lipids and the use thereof |
| 04/02/2002 | US6365564 Asymmetrical imide bleach activators and compositions employing the same |
| 04/02/2002 | US6365100 Corrosion resistance of steel in aqueous solution |
| 03/28/2002 | WO2001098236A3 7-phenyl-substituted tetracycline compounds |
| 03/28/2002 | US20020037997 Beta-amino acids |
| 03/28/2002 | US20020037895 Wherein the lactone ring is modified; preventing or treating disorders or diseases mediated by LFA-1 (Leukocyte Function-associated Antigen-1) ICAM-1 (intercellular adhesion molecules) interactions; autoimmune disorders, inflammation |
| 03/27/2002 | EP1191611A2 Piezoelectric element and process for production thereof |
| 03/27/2002 | EP1191033A2 Compositions and methods for protein structural determinations |
| 03/27/2002 | EP1189882A1 Biphenyl butyric acid derivative as a matrix metalloproteinase inhibitor |
| 03/27/2002 | CN1081625C 1-aryl-2-acylamino-ethane compounds and their use as meurokinin especially neurokinin 1 antagonists |
| 03/27/2002 | CA2321348A1 Aromatic derivatives with hiv integrase inhibitory properties |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362369 Phthalic acid diamide derivatives fluorine-containing aniline compounds as starting material, agricultural and horticultural insecticides, and a method for application of the insecticides |
| 03/26/2002 | US6362231 Calcium receptor active compounds |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | US6362174 Analgesics, antiischemic agents, antieoileptic agents |
| 03/26/2002 | US6362166 Protease inhibitor |
| 03/26/2002 | US6362165 Hydroxyphenyl derivatives with HIV integrase inhibitory properties |
| 03/21/2002 | WO2002022562A1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 03/21/2002 | WO2001079154A3 Synthesis of midodrine hci from a novel intermediate 1-(2',5'-dimethoxyphenyl)-2-azidoethanone |
| 03/21/2002 | WO2001070672A3 Compounds and methods to treat alzheimer's disease |
| 03/21/2002 | US20020035137 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035104 Integrin receptor inhibitors |
| 03/20/2002 | EP1187812A2 Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 03/20/2002 | EP1187807A1 Bipolar lipids and their use for the delivery of bioactive substances |
| 03/20/2002 | EP1187806A2 Spermine:peptide-based surfactant compounds |
| 03/20/2002 | EP0944587B1 Metalloproteinase inhibitors |
| 03/19/2002 | US6359061 Combinatorial libraries are useful for screening in biologcal assays in order to identify pharmaceutically useful compounds |
| 03/19/2002 | US6358504 Compounds and compositions for delivering active agents |
| 03/19/2002 | CA2134560C Anti-obesity drugs |
| 03/14/2002 | WO2002020820A1 Method for the preparation of enantiomerically enriched amines |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | WO2002020463A2 Fxr modulators |
| 03/14/2002 | WO2002004405A3 13-substituted methacycline compounds |
| 03/14/2002 | WO2001058852A3 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 03/14/2002 | WO2001032130A3 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 03/14/2002 | US20020032238 Lowering the plasma level of atherogenic lipoproteins; treating hyperlipidaemias, atherosclerosis or the clinical sequelae thereof, diabetes mellitus, adiposity or pancreatitis |
| 03/14/2002 | US20020032218 Substituted stilbenes as glucose uptake enhancers |
| 03/14/2002 | CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/13/2002 | EP1186305A1 New brominated compounds as contrast media for X-ray mammography |
| 03/13/2002 | EP1185526A1 Novel quaternary ammonium derivatives, method for preparing same and pharmaceutical use |
| 03/13/2002 | EP1185522A1 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions containing them |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/13/2002 | CN1340044A Nervinolin derivatives |
| 03/13/2002 | CN1340042A Preparation of iodixanol |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355726 Multicomponent ugi reaction; antisense agents, antigens; diagnosis; controlling gene expression by polymeric peptide nucleic acids |
| 03/12/2002 | US6355683 Fc receptor modulators and uses thereof |
| 03/12/2002 | US6355618 Enzyme inhibitors |
| 03/07/2002 | WO2002018323A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028801 Analgesics, antiischemic agents, antieoileptic agents |
| 03/07/2002 | US20020028799 Using protease and phospodiesterase inhibitor |
| 03/07/2002 | US20020028774 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/07/2002 | US20020028250 Carbon-substituted diketopiperazine delivery systems |
| 03/07/2002 | CA2416740A1 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/06/2002 | EP1184370A2 Compounds with growth hormone releasing properties |
| 03/06/2002 | EP1183231A1 Cytofectin dimers and methods of use thereof |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP1183074A1 Substituted biaryl ether compounds |
| 03/05/2002 | US6353124 Nonsteroidal antiinflammatory agents (aspirin, indomethacin, or ibuprofen) linked by tris amine or ethanolamine derivative to the acyl groups of fatty acids; improved transdermal delivery |
| 03/05/2002 | US6353025 Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same |
| 03/05/2002 | US6353023 Aromatic compounds with amide groups |
| 02/28/2002 | WO2002016403A1 Method of continuously degrading protein |
| 02/28/2002 | WO2002016314A1 Substituted polyamine compounds |
| 02/28/2002 | WO2002016313A2 Integrin receptor inhibitors |
| 02/28/2002 | US20020025934 Renin inhibitor |
| 02/28/2002 | US20020025920 Novel lipid complexes for transferring at least one therapeutically active substance, in particular a polynucleotide, into a target cell, and use in gene therapy |
| 02/28/2002 | US20020025401 Optical storage using materials comprising chromophore oligomers which can undergo cycloaddition |
| 02/28/2002 | CA2419580A1 Integrin receptor inhibitors |
| 02/27/2002 | EP1181266A1 Squaric acid derivatives as cell adhesion molecules |
| 02/27/2002 | EP0825991B1 Diaryldiamine derivatives and their use as delta opioid (ant)-agonists |
| 02/27/2002 | CN1079679C Cascade polymer complexes, its preparation process and medicine containing said complexes |
| 02/26/2002 | US6350908 Process for the preparation of S-N,N′-bis [2-hydroxy-1-(hydroxymethyl) ethyl]-5- [(2-hydroxy-1-oxopropyl) amino]-2,4,6-triiodo-1,3-benzenedicarboxamide |
| 02/26/2002 | US6350907 Matrix metalloprotease inhibitors |
| 02/26/2002 | US6350767 Growth hormone release stimulant |
| 02/21/2002 | WO2002014261A2 4-substituted d-glutamic acid derivatives for use as antibiotic |
| 02/21/2002 | WO2002014259A1 Calcium receptor antagonists |
| 02/21/2002 | US20020022746 Adding an alcohol to iopamidol dissolved in solvent; evaporating crystallizing solvent from iopamidol solution so as to precipitate solid iopamidol |
| 02/21/2002 | US20020022647 2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |